<DOC>
	<DOCNO>NCT00803790</DOCNO>
	<brief_summary>This study evaluate bioequivalence alendronate combination vitamin D compare alendronate alone bioequivalence vitamin D combination alendronate compare vitamin D alone . This open-label , randomize , 2-part , crossover study . Each participant participate one part study ( i.e. , participant participate Part I Part II ) . Participants enter study sequentially within part study . A washout least 12 day separate treatment period within part study .</brief_summary>
	<brief_title>A Study Bioequivalence 70-mg Alendronate 70-mg Alendronate Combination With 5600 IU Vitamin D ( MK0217A-253 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Male nonpregnant female age 18 85 year female childbearing potential appropriate method contraception nurse Body Mass Index ( BMI ) less equal 30 kg/m2 subject good health mental legal incapacitation receive bisphosphonate treatment within 3 month enrollment . unable sit stand upright least 2 hour unwilling refrain consumption alcohol caffeinated product 24 hour prior 36 hour study drug administration unwilling limit alcohol consumption 2 drink per day unwilling limit caffeinated product equivalent 4 cup coffee per day equivalent . unwilling refrain smoking study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>